Non-invasive imaging of unstable atherosclerotic plaques prone to rupture remains an unmet need in clinical cardiology. This is because current imaging modalities provide information on plaque burden, luminal stenosis and calcification, whereas they have limited ability to discern unstable from stable plaques. We used the tandem stenosis mouse model of unstable plaque in conjunction with MRI and a sensor (bis-5-hydroxytryptamide-DTPA-Gd) for the activity of the inflammatory enzyme myeloperoxidase. Our results reveal sustained and greater enhancement of unstable experimental plaque with the targeted sensor compared with its non-targeted analog (DTPA-Gd), and these results were confirmed by separate biochemical and histological analyses.
This abstract and the presentation materials are available to members only; a login is required.